Brief: Virios Therapeutics Announces Termination Of At-The-Market Sales Agreement
18/09/2023 12:11
Sept 18 (Reuters) - Virios Therapeutics Inc VIRI.O :
* VIRIOS THERAPEUTICS ANNOUNCES TERMINATION OF AT-THE-MARKET
SALES
AGREEMENT
* VIRIOS THERAPEUTICS- PROVIDED NOTICE OF TERMINATION OF
SALES
DEAL ENTERED INTO BETWEEN CO & JONESTRADING INSTITUTIONAL
SERVICES LLC ON JULY 14, 2023
Source text for Eikon: ID:nGNX3MDl9Y
Further company coverage: VIRI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dogwood Therapeutics
See all newsDogwood Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Dogwood Therapeutics Q2 net loss widens on higher costs, impairment charge
Brief: Dogwood Therapeutics Q2 EPS USD -0.34
Dogwood Therapeutics Inc expected to post a loss of 14 cents a share - Earnings Preview
Brief: Dogwood Therapeutics Announces Commencement Of Halneuron® Chemotherapy Induced Neuropathic Pain Phase 2B Long Term Extension Study